Teva Pharmaceutical Industries (TEVA) Preferred Shares (2015 - 2018)

Teva Pharmaceutical Industries has disclosed Preferred Shares across 4 years of filings, most recently posting $3.8 billion for Q3 2018.

• Quarterly Preferred Shares changed N/A year-over-year to $3.8 billion in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $3.8 billion (changed N/A YoY) and the FY2017 annual result came in at $3.6 billion, changed 0.3% from the prior year.
• Preferred Shares climbed to $3.8 billion in Q3 2018, from $3.8 billion in the prior quarter.
• Over five years, Preferred Shares peaked at $3.8 billion in Q3 2018 and troughed at $3.3 billion in Q4 2015.
• A 4-year average of $3.6 billion and a median of $3.7 billion in 2017 frame the typical range for Preferred Shares.
• Annual changes were most pronounced in 2016 — Preferred Shares advanced 10.0% — and 2017, when it gained 0.3%.
• Tracing TEVA's Preferred Shares over 4 years: stood at $3.3 billion in 2015, then advanced by 10.0% to $3.6 billion in 2016, then grew by 0.3% to $3.6 billion in 2017, then gained by 5.34% to $3.8 billion in 2018.
• Business Quant data shows TEVA's Preferred Shares at $3.8 billion in Q3 2018, $3.8 billion in Q2 2018, and $3.7 billion in Q1 2018.